PPL
JAZZ icon

Planning Project LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Planning Project LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.19K Buy
+7
New +$1.07K ﹤0.01% 135

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Planning Project LLC's JAZZ Position: Q4 2025 in Review

Planning Project LLC opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2025: 7 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #135 among its holdings.

574 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • Planning Project LLC held 7 shares of Jazz Pharmaceuticals worth $1.19K as of Q4 2025.
  • Jazz Pharmaceuticals was a new Planning Project LLC position in Q4 2025.
  • Jazz Pharmaceuticals made up ﹤0.01% of Planning Project LLC's portfolio in Q4 2025, its #135 holding.
  • 574 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on Planning Project LLC's 13F filing for Q4 2025, filed 12 Feb 2026.